Aerpio Pharmaceuticals, Inc. (ARPO): Price and Financial Metrics

Aerpio Pharmaceuticals, Inc. (ARPO): $33.00

0.30 (-0.90%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ARPO to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#418 of 508

in industry

ARPO Price/Volume Stats

Current price $33.00 52-week high $34.50
Prev. close $2.22 52-week low $0.95
Day low $32.40 Volume 55,066
Day high $34.50 Avg. volume 5,147,753
50-day MA $2.04 Dividend yield N/A
200-day MA $1.64 Market Cap 1.57B

ARPO Stock Price Chart Interactive Chart >


Aerpio Pharmaceuticals, Inc. (ARPO) Company Bio


Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is based in Cincinnati, Ohio


ARPO Latest News Stream


Event/Time News Detail
Loading, please wait...

ARPO Latest Social Stream


Loading social stream, please wait...

View Full ARPO Social Stream

ARPO Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching ARPO

Here are a few links from around the web to help you further your research on Aerpio Pharmaceuticals Inc's stock as an investment opportunity:

Aerpio Pharmaceuticals Inc (ARPO) Stock Price | Nasdaq
Aerpio Pharmaceuticals Inc (ARPO) Stock Quote, History and News - Yahoo Finance
Aerpio Pharmaceuticals Inc (ARPO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!